Publication | Closed Access

The adjuvant effect of synthetic oligodeoxynucleotide containing CpG motif converts the anti-Haemophilus influenzae type b glycoconjugates into efficient anti-polysaccharide and anti-carrier polyvalent vaccines

VaccinationMucosal VaccinationCross-protectionVaccine DevelopmentAnti-carrier Polyvalent VaccinesMedicineAdjuvant EffectImmunologyCpg MotifImmunodominanceVaccine DesignPolyvalent VaccinePrecision VaccinologyVaccine Research